MobileODT completed $4 million series round C

The round will support the development of AI cervical cancer screening device MobileODT, the developer of the EVA System for cervical cancer screening, announced the completion of a $4 million series C fundraising round. The round will enable MobileODT to further...

MobileODT completes second institutional financing

MobileODT is pleased to announce it has successfully completed its second round of institutional financing. The announcement comes shortly before the launch of its AI-based cervical cancer screening test, VisualPap. OrbiMed Israel Advisors led the round, with Tara...

Media Contact:

<a class="twitter-timeline" data-height="3500" href="">Tweets by MobileODT</a> <script async src="" charset="utf-8"></script>

Pin It on Pinterest